glp-1 news updates 💊New pill gets FDA approval, and has fewer restrictions on how it's used💊 GLP-1 weight loss drugs leave

No, GLP-1 agonist drugs are 100 times more potent

January 15, 2026: FDA Posts Updates to Mounjaros Drug Warning Label, Strengthening Gastrointestinal Warnings On December 19, 2025, and January 7, 2026, the FDA published updates to Mounjaros drug warning label

Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway

This restriction would be lifted once we restock

Read More Hide About the brand They say: "Bloommy began with a determination to show the power of nature, creating anti-aging skin care products using healthy organic ingredients without compromising performance." Disclaimer The information provided here is based on public brand-provided information and based on commonly known practices and formulation guidelines in the cosmetic industry

Fr du setter i gang, sett deg et klart budsjett og bestem tidsrammer for spillktene